We provide the first evidence that RNF34 exacerbates oxidative stress, brain injury, and dyskinesia by reducing PGC-1α expression and potentiating mitochondrial dysfunction in the ICH mouse model. The gene discussed is RNF34; the disease is drug-induced dyskinesia.